TapImmune
Why Robinhood?
You can watch TapImmune and buy or sell other stocks, ETFs, and their options commission-free!About TPIV
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
TPIV Key Statistics
Stock Snapshot
TapImmune(TPIV) stock is priced at $2.55, giving the company a market capitalization of 25.18M. It carries a P/E multiple of -2.24.
On 2026-05-29, TapImmune(TPIV) stock opened at —, reached a high of —, and a low of —.
The TapImmune(TPIV)'s current trading volume is 0, compared to an average daily volume of 59.79K.
During the past year, TapImmune(TPIV) stock moved between $0.81 at its lowest and $4.07 at its peak.
During the past year, TapImmune(TPIV) stock moved between $0.81 at its lowest and $4.07 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.